We now know how much Sucampo founders made from the company's sale

New regulatory filings were disclosed this week after Sucampo Pharmaceuticals closed on its $1.2 billion sale to Mallinckrodt.

Source: bizjournals.com Health Care:Biotechnology headlines - February 16, 2018 Category: Biotechnology Authors: Tina Reed Source Type: news